A phase II trial of the combination of S-1 and paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with HER2-negative, stage II/III breast cancer. (March 2017)

Record Type:: Journal Article
Title:: A phase II trial of the combination of S-1 and paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with HER2-negative, stage II/III breast cancer. (March 2017)
Main Title:: A phase II trial of the combination of S-1 and paclitaxel followed by 5-FU/epirubicin/cyclophosphamide (FEC) as preoperative treatment in women with HER2-negative, stage II/III breast cancer
Authors:: Takahashi, Y.
Jinno, H.
Yoshikawa, M.
Matsumoto, A.
Ikeda, T.
Abstract:
Is Part Of:: Breast. Volume 32(2017)Supplement 1
Journal:: Breast
Issue:: Volume 32(2017)Supplement 1
Issue Display:: Volume 32, Issue 1 (2017)
Year:: 2017
Volume:: 32
Issue:: 1
Issue Sort Value:: 2017-0032-0001-0000
Page Start:: S82
Page End:
Publication Date:: 2017-03
Subjects:: Breast -- Diseases -- Periodicals
Breast -- Tumors -- Periodicals
Breast -- Periodicals
Electronic journals
Periodicals
616
Journal URLs:: http://www.sciencedirect.com/science/journal/09609776 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0960-9776;screen=info;ECOIP ↗
http://www.harcourt-international.com/journals/brst/ ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09609776 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09609776 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0960-9776(17)30267-9 ↗
Languages:: English
ISSNs:: 0960-9776
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 2277.492700
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 2532.xml